These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 23579027

  • 1. Differential regulation of B-cell proliferation by IL21 in different subsets of chronic lymphocytic leukemia.
    Ghalamfarsa G, Jadidi-Niaragh F, Hojjat-Farsangi M, Asgarian-Omran H, Yousefi M, Tahmasebi F, Khoshnoodi J, Razavi SM, Saboor-Yaraghi AA, Rabbani H, Jeddi-Tehrani M, Shokri F.
    Cytokine; 2013 Jun; 62(3):439-45. PubMed ID: 23579027
    [Abstract] [Full Text] [Related]

  • 2. All-trans-retinoic Acid differentially regulates proliferation of normal and leukemic B cells from different subsets of chronic lymphocytic leukemia.
    Ghalamfarsa G, Jadidi-Niaragh F, Amiri MM, Razavi SM, Saboor-Yaraghi AA, Shokri F.
    Nutr Cancer; 2015 Jun; 67(2):285-91. PubMed ID: 25611428
    [Abstract] [Full Text] [Related]

  • 3. The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease.
    Longo PG, Laurenti L, Gobessi S, Petlickovski A, Pelosi M, Chiusolo P, Sica S, Leone G, Efremov DG.
    Leukemia; 2007 Jan; 21(1):110-20. PubMed ID: 17024114
    [Abstract] [Full Text] [Related]

  • 4. Synergistic induction of apoptosis in B-cell chronic lymphocytic leukemia cells after treatment with all-trans retinoic acid in combination with interleukin-21 and rituximab.
    Abbaszadeh-Goudarzi K, Shokri F, Hosseini M, Jadidi-Niaragh F, Ghalamfarsa G, Saboor-Yaraghi AA.
    J Cancer Res Ther; 2016 Jan; 12(4):1278-1283. PubMed ID: 28169240
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia.
    Ahearne MJ, Willimott S, Piñon L, Kennedy DB, Miall F, Dyer MJ, Wagner SD.
    Br J Haematol; 2013 Aug; 162(3):360-70. PubMed ID: 23710828
    [Abstract] [Full Text] [Related]

  • 6. Effect of interleukin 21 and/or interleukin 12 on the antitumor activity of peripheral blood mononuclear cells in patients with endometrial cancer.
    Tian YJ, Cui BX, Ma DX, Zhang Y, Hou F, Zhang WJ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Jun; 33(3):292-8. PubMed ID: 21718613
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A, Rolinski J, Wasik-Szczepaneko E, Kaluzny Z, Dmoszynska A.
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
    Tromp JM, Tonino SH, Elias JA, Jaspers A, Luijks DM, Kater AP, van Lier RA, van Oers MH, Eldering E.
    Oncogene; 2010 Sep 09; 29(36):5071-82. PubMed ID: 20581863
    [Abstract] [Full Text] [Related]

  • 11. The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia.
    Tarnani M, Laurenti L, Longo PG, Piccirillo N, Gobessi S, Mannocci A, Marietti S, Sica S, Leone G, Efremov DG.
    Leuk Res; 2010 Sep 09; 34(9):1189-94. PubMed ID: 20074801
    [Abstract] [Full Text] [Related]

  • 12. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
    Coscia M, Pantaleoni F, Riganti C, Vitale C, Rigoni M, Peola S, Castella B, Foglietta M, Griggio V, Drandi D, Ladetto M, Bosia A, Boccadoro M, Massaia M.
    Leukemia; 2011 May 09; 25(5):828-37. PubMed ID: 21372840
    [Abstract] [Full Text] [Related]

  • 13. Lenalidomide Induces Interleukin-21 Production by T Cells and Enhances IL21-Mediated Cytotoxicity in Chronic Lymphocytic Leukemia B Cells.
    Browning RL, Byrd WH, Gupta N, Jones J, Mo X, Hertlein E, Yu L, Muthusamy N, Byrd JC.
    Cancer Immunol Res; 2016 Aug 09; 4(8):698-707. PubMed ID: 27287425
    [Abstract] [Full Text] [Related]

  • 14. B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21.
    Hagn M, Blackwell SE, Beyer T, Ebel V, Fabricius D, Lindner S, Stilgenbauer S, Simmet T, Tam C, Neeson P, Trapani JA, Schrezenmeier H, Weiner GJ, Jahrsdörfer B.
    Int Immunol; 2014 Jul 09; 26(7):383-95. PubMed ID: 24497611
    [Abstract] [Full Text] [Related]

  • 15. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M, Jeddi-Tehrani M, Razavi SM, Sharifian RA, Shamsian Khoramabadi A, Rabbani H, Shokri F.
    Iran J Immunol; 2008 Mar 09; 5(1):25-35. PubMed ID: 18319522
    [Abstract] [Full Text] [Related]

  • 16. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.
    Cahill N, Bergh AC, Kanduri M, Göransson-Kultima H, Mansouri L, Isaksson A, Ryan F, Smedby KE, Juliusson G, Sundström C, Rosén A, Rosenquist R.
    Leukemia; 2013 Jan 09; 27(1):150-8. PubMed ID: 22922567
    [Abstract] [Full Text] [Related]

  • 17. Leukemic cells from progressive B-CLL respond strongly to growth stimulation in vitro.
    Aguilar-Santelises M, Mellstedt H, Jondal M.
    Leukemia; 1994 Jul 09; 8(7):1146-52. PubMed ID: 8035606
    [Abstract] [Full Text] [Related]

  • 18. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P, Tiribelli M, Barbarotto E, Celeghini C, Michelutti A, Masolini P, Fanin R, Zauli G.
    J Cell Physiol; 2005 Nov 09; 205(2):246-52. PubMed ID: 15887227
    [Abstract] [Full Text] [Related]

  • 19. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D, Ciszak L, Kosmaczewska A, Bocko D, Teodorowska R, Frydecka I, Kuliczkowski K.
    Haematologica; 2001 Dec 09; 86(12):1296-304. PubMed ID: 11726322
    [Abstract] [Full Text] [Related]

  • 20. Evaluating the mechanism underlying antitumor effect of interleukin 27 on B cells of chronic lymphocytic leukemia patients.
    Manouchehri-Doulabi E, Abbaspour S, Rostami S, Faranoush M, Ghahramanfard F, Pak F, Barati M, Kokhaei P, Momtazi-Borojeni AA.
    J Cell Physiol; 2020 Dec 09; 235(12):9424-9431. PubMed ID: 32383245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.